Contact: DOH Communications
FLORIDA BOARD OF PHARMACY ISSUES SURVEYS ON COMPOUNDING PRACTICES
~Emergency rule requires pharmacies to provide information ~
TALLAHASSEE- The Florida Board of Pharmacy has issued electronic surveys to all licensed pharmacies, both in state and non-resident, to determine their compounding activities. During a special meeting held last week in Orlando, the Board approved an emergency rule that requires licensed pharmacies to provide this information within 14 days. Non-resident pharmacies are required to provide copies of their two most recent inspection reports.
“This survey will provide critical information into the compounding practices of pharmacies in Florida,” said Division Director of Medical Quality Assurance Lucy Gee, M.S. “The nationwide fungal meningitis outbreak raised important questions about the safety of compounding practices in general, and we must ensure that compounded medications in Florida are safe for the people of Florida.”
The special meeting of the Board and the emergency rule were in response to New England Compounding Center’s (NECC) contaminated injectable steroids that were compounded and affected 510 individuals, including 36 deaths nationwide. NECC is currently under investigation by the Food and Drug Administration and Congressional hearings have been held in light of a nationwide outbreak of fungal meningitis. The Florida Department of Health obtained a voluntary relinquishment of NECC’s permit preventing the company from reapplying for licensure in the state. There are no NECC products available in patient health care settings in Florida.
The survey can be found on the Florida Department of Health Board of Pharmacy website at http://www.doh.state.fl.us/mqa/pharmacy/survey.html.
The Florida Department of Health works to protect, promote, and improve the health of all people in Florida through integrated state, county, and community efforts.